Cannabis and Psychedelics Among U.S. Young Adults: Use, Messaging Exposure, Perceptions, and Legalization Support

This study assessed the correlates of cannabis and psychedelic use and legalization support among young adults in the United States (US). Using 2025 data among adults ages 18-34 (<i>n</i> = 3227), we assessed cannabis and psychedelic message exposure and perceptions, mental health symptoms (Patient Health Questionnaire-4 [PHQ-4]), and adverse childhood experiences (ACEs) in relation to past-6-month cannabis use (40.5%), past-year psychedelic use (11.9%), and legalization support. Relative to cannabis, psychedelics showed less legalization support, promotional and risk-message exposure, and social acceptability and higher perceived addictiveness and harm (<i>p</i>'s < 0.001). Factors associated with cannabis use and greater legalization support included: lower perceived addictiveness (aOR = 0.88, CI = 0.83-0.93; B = -0.04, SE = 0.01) and harm (aOR = 0.75, CI = 0.71-0.80; B = -0.16, SE = 0.01), higher social acceptability (aOR = 1.25, CI = 1.19-1.33; B = 0.19, SE = 0.01), and higher PHQ-4 (aOR = 1.04, CI = 1.01-1.07); more ACEs (aOR = 1.10, CI = 1.06-1.14) and more promotional (aOR = 1.08, CI = 1.01-1.17) and risk-message exposure (aOR = 1.27, CI = 1.17-1.39) were associated with use. Factors associated with psychedelic use and greater legalization support included: more promotional-message exposure (aOR = 1.61, CI = 1.36-1.91; B = 0.09, SE = 0.04), lower addictiveness (aOR = 0.87, CI = 0.78-0.97; B = -0.03, SE = 0.02) and harm (aOR = 0.74, CI = 0.66-0.82; B = -0.19, SE = 0.02), higher acceptability (aOR = 1.59, CI = 1.47-1.73; B = 0.15, SE = 0.01), and higher PHQ-4 (aOR = 1.06, CI = 1.02-1.11; B = 0.02, SE = 0.01); more risk-message exposure (aOR = 1.29, CI = 1.08-1.54) and ACEs (aOR = 1.15, CI = 1.09-1.21) were associated with use. Perceptions and mental health may influence cannabis and psychedelic use and legalization support, and message exposure may be particularly relevant in shaping psychedelic use and legalization support. Thus, information is crucial to ensure population understanding of the risks, benefits, and overall population impacts of cannabis and psychedelic use and legalization.

Authors

Institutions

Publication Details

Journal
International Journal of Environmental Research and Public Health
Published
2026-02-17
DOI
https://doi.org/10.3390/ijerph23020255
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabis and Psychedelics Among U.S. Young Adults: Use, Messaging Exposure, Perceptions, and Legalization Support

Cassidy R. LoParco, Darcey M. McCready, Diane Ndisebuye, Shriya Thakkar et al.
International Journal of Environmental Research and Public Health
Psychedelics and Drug Studies
article

Cannabis and Psychedelics Among U.S. Young Adults: Use, Messaging Exposure, Perceptions, and Legalization Support

Cassidy R. LoParco, Darcey M. McCready, Diane Ndisebuye, Shriya Thakkar, Erin Kasson, Laura C. Schubel, Patricia A. Cavazos-Rehg, Y. Tony Yang, Carla J. Berg
article en

Abstract

This study assessed the correlates of cannabis and psychedelic use and legalization support among young adults in the United States (US). Using 2025 data among adults ages 18-34 (<i>n</i> = 3227), we assessed cannabis and psychedelic message exposure and perceptions, mental health symptoms (Patient Health Questionnaire-4 [PHQ-4]), and adverse childhood experiences (ACEs) in relation to past-6-month cannabis use (40.5%), past-year psychedelic use (11.9%), and legalization support. Relative to cannabis, psychedelics showed less legalization support, promotional and risk-message exposure, and social acceptability and higher perceived addictiveness and harm (<i>p</i>'s < 0.001). Factors associated with cannabis use and greater legalization support included: lower perceived addictiveness (aOR = 0.88, CI = 0.83-0.93; B = -0.04, SE = 0.01) and harm (aOR = 0.75, CI = 0.71-0.80; B = -0.16, SE = 0.01), higher social acceptability (aOR = 1.25, CI = 1.19-1.33; B = 0.19, SE = 0.01), and higher PHQ-4 (aOR = 1.04, CI = 1.01-1.07); more ACEs (aOR = 1.10, CI = 1.06-1.14) and more promotional (aOR = 1.08, CI = 1.01-1.17) and risk-message exposure (aOR = 1.27, CI = 1.17-1.39) were associated with use. Factors associated with psychedelic use and greater legalization support included: more promotional-message exposure (aOR = 1.61, CI = 1.36-1.91; B = 0.09, SE = 0.04), lower addictiveness (aOR = 0.87, CI = 0.78-0.97; B = -0.03, SE = 0.02) and harm (aOR = 0.74, CI = 0.66-0.82; B = -0.19, SE = 0.02), higher acceptability (aOR = 1.59, CI = 1.47-1.73; B = 0.15, SE = 0.01), and higher PHQ-4 (aOR = 1.06, CI = 1.02-1.11; B = 0.02, SE = 0.01); more risk-message exposure (aOR = 1.29, CI = 1.08-1.54) and ACEs (aOR = 1.15, CI = 1.09-1.21) were associated with use. Perceptions and mental health may influence cannabis and psychedelic use and legalization support, and message exposure may be particularly relevant in shaping psychedelic use and legalization support. Thus, information is crucial to ensure population understanding of the risks, benefits, and overall population impacts of cannabis and psychedelic use and legalization.

International Journal of Environmental Research and Public HealthVol. 23(2)
Milken Institute (US), George Washington University (US), Washington University in St. Louis (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 55%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.